Literature DB >> 31264302

Natural compounds in the chemoprevention of alcoholic liver disease.

Yingfeng Tu1, Shu Zhu2, Jing Wang1, Ezra Burstein3, Da Jia1.   

Abstract

Alcoholic liver disease (ALD), caused by excessive consumption of alcohol, is a major cause of chronic liver disease worldwide. Much effort has been expended to explore the pathogenesis of ALD. Hepatic cell injury, oxidative stress, inflammation, regeneration, and bacterial translocation are all involved in the pathogenesis of ALD. Immediate abstinence is the most important therapeutic treatment for affected individuals. However, the medical treatment for ALD had not advanced in a long period. Intriguingly, an increasing body of research indicates the potential of natural compounds in the targeted therapy of ALD. A plethora of dietary natural products such as flavonoids, resveratrol, saponins, and β-carotene are found to exert protective effects on ALD. This occurs through various mechanisms composed of antioxidative, anti-inflammatory, iron chelation, pro-apoptosis, and/or antiproliferation of hepatic stellate cells and hepatocellular carcinoma cells. In this review, we will summarize current knowledge about the pathogenesis and treatments of ALD and focus on the potential of natural compounds in ALD therapies and underlying mechanisms.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  alcoholic liver disease; flavonoids; resveratrol; saponins; β-carotene

Mesh:

Substances:

Year:  2019        PMID: 31264302     DOI: 10.1002/ptr.6410

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  7 in total

1.  Chemical Components and Hepatoprotective Mechanism of Xwak Granule in Mice Treated with Acute Alcohol.

Authors:  Li Chen; Liu Liu; Rahima Abdulla; Xirali Tursun; Xuelei Xin; Haji Akber Aisa
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-28       Impact factor: 2.629

2.  Aronia melanocarpa Prevents Alcohol-Induced Chronic Liver Injury via Regulation of Nrf2 Signaling in C57BL/6 Mice.

Authors:  Zhuqian Wang; Yange Liu; Xuyu Zhao; Shuyan Liu; Yang Liu; Di Wang
Journal:  Oxid Med Cell Longev       Date:  2020-01-08       Impact factor: 6.543

Review 3.  Emerging Roles of SIRT1 in Alcoholic Liver Disease.

Authors:  Ruixue Ren; Ziming Wang; Miaomiao Wu; Hua Wang
Journal:  Int J Biol Sci       Date:  2020-10-17       Impact factor: 6.580

4.  Optimized preparation of gastric acid-response sulfhydryl functionalized chitosan/alginate/tilapia peptide hydrogel and its protective effects on alcohol-induced liver and brain injury.

Authors:  Sitong Lu; Lingyu Zhang; Zhang Hu; Songzhi Kong; Zhaoyu Zhang; Guangfa Li
Journal:  RSC Adv       Date:  2021-10-26       Impact factor: 4.036

5.  Lactoferrin Prevents Chronic Alcoholic Injury by Regulating Redox Balance and Lipid Metabolism in Female C57BL/6J Mice.

Authors:  De-Ming Li; Yun-Xuan Wu; Zhi-Qiang Hu; Tian-Ci Wang; Li-Li Zhang; Yan Zhou; Xing Tong; Jia-Ying Xu; Li-Qiang Qin
Journal:  Antioxidants (Basel)       Date:  2022-07-31

6.  Sinapic Acid Reduces Oxidative Stress and Pyroptosis via Inhibition of BRD4 in Alcoholic Liver Disease.

Authors:  Junyi Chu; Ran Yan; Sai Wang; Guoyang Li; Xiaohui Kang; Yan Hu; Musen Lin; Wen Shan; Yan Zhao; Zhecheng Wang; Ruimin Sun; Jihong Yao; Ning Zhang
Journal:  Front Pharmacol       Date:  2021-06-04       Impact factor: 5.810

7.  Veratramine suppresses human HepG2 liver cancer cell growth in vitro and in vivo by inducing autophagic cell death.

Authors:  Linlin Yin; Yonghui Xia; Ping Xu; Wenli Zheng; Yuanyuan Gao; Faqin Xie; Zhaoning Ji
Journal:  Oncol Rep       Date:  2020-05-25       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.